Venous Occlusion Clinical Trial
Official title:
Effect of Aspirin and Clopidogrel in Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator
The purpose of this study is to determine whether Aspirin or Clopidogrel are effective in the prevention of venous obstruction after implantation of cardiac pacemaker or defibrillator.
There are growing numbers of endocardial permanent pacemakers (PPM) and implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT) device. Asymptomatic obstruction of the access vein reported to have a high incidence (30-50%) in some studies. This complication can cause some difficulties in follow up procedures such as device upgrading. The purpose of this study is to determine whether Aspirin or Clopidogrel are effective in the prevention of venous obstruction after implantation of cardiac pacemaker or defibrillator. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05409976 -
The GORE® VIAFORT Vascular Stent IVC Study
|
N/A | |
Terminated |
NCT02241343 -
Venous Occlusion and Limb Swelling
|
N/A | |
Active, not recruiting |
NCT04540302 -
The Merit WRAPSODY AV Access Efficacy Study (WAVE)
|
N/A | |
Not yet recruiting |
NCT06096142 -
The Solaris DE Endoprosthesis for the Treatment of AV Access Stenosis or Occlusion
|
N/A | |
Withdrawn |
NCT04541576 -
The Merit WRAPSODY Central Feasibility Study
|
N/A | |
Recruiting |
NCT05489588 -
The GORE® VIAFORT Vascular Stent Iliofemoral Study
|
N/A | |
Recruiting |
NCT05062291 -
Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP)
|
||
Completed |
NCT03644017 -
The Merit WRAPSODY™ Endovascular Stent Graft
|
N/A | |
Recruiting |
NCT04995432 -
Non Contrast MRI in Lower Extremity
|
||
Completed |
NCT03209050 -
Evaluation of the Surfacer System Approach to Central Venous Access
|
N/A |